Apister Lifesciences Private Limited, a active private limited company, was established on 01 May 2017 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304GJ2017PTC097161. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.38 M.
It upholds a compliant status. Employing 58 professional, Its leadership includes Ami Hemal Patel (Director), Hemal Naranbhai Patel (Director). Past directors included Hasmukhbhai Naranbhai Patel, Tusharkumar Rameshbhai Patel, Nirav Nalinkumar Vyas. It holds no open charges and ₹17.90 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block - A, Shop -114, Ganesh Meridian Opp. High Court, S.G. Highway, Ghatlodia, Ahmedabad, Gujarat, 380061.
U24304GJ2017PTC097161
097161
01 May 2017
₹0.50 M
₹0.38 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Apister Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ami Hemal Patel | Director | 05 Jul 2025 | Current |
| Hemal Naranbhai Patel | Director | 01 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 May 2025 | Past |
| Pramod Abcsdd | Director | 30 Oct 2018 | Past |
| Pramod Abcsdd | Director | 05 Nov 2018 | Past |
| Pramod Abcsdd | Director | 01 Jan 2025 | Past |
| Pramod Abcsdd | Director | 01 Jan 2025 | Past |
| Pramod Abcsdd | Director | 13 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apister Lifesciences Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 8.61% decrease. The company also saw a substantial improvement in profitability, with a 16.5% increase in profit. The company's net worth Soared by an impressive increase of 29.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Apister Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹179,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2020 | Others | ₹8.00 Cr | Satisfied |
| 24 Apr 2020 | Others | ₹2.50 M | Satisfied |
| 11 Aug 2017 | Others | ₹9.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Apister Lifesciences has a workforce of 58 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apister Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apister Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ami Hemal Patel was appointed as a Director was appointed as a Director on 05 Jul 2025 & has been associated with this company since 4 months 24 days . was recorded as a recent event.
The activity A charge registered on 24 Apr 2020 via Charge ID 100346229 with Others was fully satisfied on 18 Jan 2025. was completed.
The activity Hemal Naranbhai Patel was appointed as a Director was appointed as a Director on 01 Jan 2025 & has been associated with this company since 10 months 25 days . was completed.
A charge registered on 11 Aug 2017 via Charge ID 100129254 with Others was fully satisfied on 31 Dec 2024. was recorded as a recent event.
Progress on A charge registered on 08 Jul 2020 via Charge ID 100401867 with Others was fully satisfied on 08 Oct 2024. was documented.
Apister Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Apister Lifesciences Private Limited is U24304GJ2017PTC097161.
Apister Lifesciences Private Limited is headquartered at Block - A, Shop -114, Ganesh Meridian Opp. High Court, S.G. Highway, Ghatlodia, Ahmedabad, Gujarat, 380061.
Apister Lifesciences Private Limited was incorporated on 01 May 2017.
The current directors of Apister Lifesciences Private Limited are
The primary industry of Apister Lifesciences Private Limited is Manufacturing.
Apister Lifesciences Private Limited is unlisted.
The authorized capital of Apister Lifesciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.38 M.
The compliance status of Apister Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX